Clinical Trials Advisor

Adaptive clinical trials can allow sites to enroll small numbers of patients and end a trial early if the desired outcome appears unlikely, but investigators must take care to ensure that study participants understand they are consenting to a moving protocol and that patients who enroll later may see more benefits than early enrollees, a pair of recent articles in Journal of the American Medical Association (JAMA) suggests.